Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (403)

clinicaltrialsPublishedShowing 601–650 of 843 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03340636	Residual Plasma Concentration of Sorafenib and Adverse Events in CHC(PharmacoCHC)	unknown	—	60	University Hospital, CaenOTHER	1	Nov 13, 2017	clinicaltrials
NCT03337841	Pembrolizumab as Neoadjuvant Treatment in HCC	unknown	Phase 2	50	Kindai UniversityOTHER	0	Nov 9, 2017	clinicaltrials